Company Filing History:
Years Active: 2025
Title: David Rudlstorfer: Innovator in Pulmonary Drug Delivery
Introduction
David Rudlstorfer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pulmonary drug delivery through his innovative methods and systems. His work focuses on enhancing the efficacy of aerosol-based drug delivery systems.
Latest Patents
David Rudlstorfer holds a patent for a "Method for assessing the efficacy of an aerosol for pulmonary drug delivery as well as inhaler device, orally inhaled and/or nasal drug product and drug/device combination product." This invention relates to systems and methods for evaluating the effectiveness of aerosols used in pulmonary drug delivery. The patent outlines a process that includes providing a computational lung model and a computational particle transport and deposition model. It computes a spatial particle deposition distribution of discrete particles based on aerosol parameters and assesses the efficacy of the aerosol for pulmonary drug delivery.
Career Highlights
David is associated with Ebenbuild GmbH, where he applies his expertise in developing advanced inhaler devices and drug products. His innovative approach has positioned him as a key player in the field of respiratory therapeutics.
Collaborations
He collaborates with talented individuals such as Jonas Biehler and Karl-Robert Klaus Wichmann, contributing to the advancement of aerosol technology and drug delivery systems.
Conclusion
David Rudlstorfer's work in pulmonary drug delivery exemplifies the impact of innovation in healthcare. His patent and collaborations highlight the importance of effective drug delivery systems in improving patient outcomes.